Search | VHL Regional Portal

Rituximab and rapamycin for posttransplant lymphoproliferative disease treatment: report of three cases.

Garcia, V D; Bonamigo-Filho, J S; Neumann, J; Fogliatto, L; Gaiger, A M; Garcia, C D; Barros, V; Keitel, E; Bittar, A E; Santos, A F; Roithmann, S.

Transplant Proc ; 34(7): 2993-5, 2002 Nov.

Article in English | MEDLINE | ID: mdl-12431680

Subject(s)

Antibodies, Monoclonal/therapeutic use , Immunosuppressive Agents/therapeutic use , Kidney Transplantation/adverse effects , Lymphoproliferative Disorders/drug therapy , Postoperative Complications/drug therapy , Sirolimus/therapeutic use , Adolescent , Adult , Antibodies, Monoclonal, Murine-Derived , Humans , Male , Rituximab

See more details

SEND TO:

Export

RSS

XML

SELECTION OF CITATIONS

List items (0)
Clear list

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL